This trial is an interrogation of patients with prostate cancer to evaluate socioeconomic effects of radiotherapy. Patients with percutaneous or interstitial or combined percutaneous and interstitial radiotherapy are included. Beside medical effects and adverse events, it's prospectively needed to extensively inform patients about socioeconomic aspects associated with radiotherapy. The interrogation comprises to collect possible costs and expenditures during and after therapy. Aspects especially concerning post therapy period include additional consultations, individual applied alternative medical care, need for additional medical aids (salves, medicine, bandages) and changes in professional and social situation. It's figured out in what extend costs are absorbed by health insurance coverage. In Germany there is no appropriate trial with respective patient population and respective therapy. Primary endpoint is the evaluation of therapy concerning and follow-up costs as well as changes in social and professional situation. Secondary endpoints are quality of life, adverse events of therapy and the correlation of quality of life, adverse events and economic aspects for the patient and the health insurance coverage.
Study Type
OBSERVATIONAL
Enrollment
60
patients receive questionnaires regarding socioeconomic aspects before, during and after therapy
Universitätsklinikum Erlangen
Erlangen, Germany
RECRUITINGtherapy concerning and follow-up costs associated with changes in social professional situation that is connected with Quality of life
by questionnaires concerning social aspects and quality of life to evaluate connections between these parameters
Time frame: Participants will be followed for the duration of therapy and for 1 year after the last study treatment
adverse events
Time frame: Participants will be followed for the duration of therapy and for 1 year after the last study treatment
correlation of quality of life, adverse events and economic aspects for the patient and the health insurance coverage
Time frame: Participants will be followed for the duration of therapy and for 1 year after the last study treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.